Omnicell’s Shares Down 5% Following Q4 Results
<p><a href='https://financialmodelingprep.com/financial-summary/OMCL'>Omnicell, Inc. (NASDAQ:OMCL) </a>shares closed more than 5% lower today following the company’s reported Q4 results, with quarterly EPS of $0.92 coming in 3.2% lower than the consensus estimate. Revenue of $311.7 million was in line with the Street estimates.</p>
<p>The company expects Q1/22 EPS in the range of $0.65-$0.72, compared to the consensus estimate of $0.86. Q1 revenue is expected to range from $312 million to 318 million, compared to the consensus estimate of $301.38 million.</p>
<p>According to the analysts at Berenberg Bank, inflationary pressures look more concerning in the near term than previously anticipated, but strong product bookings and backlog support their long-term revenue outlook. </p>
<p>The analysts expect raw material inflation to weigh on profitability longer than initially anticipated and believe conservatively that reaching the 25% adjusted EBITDA margin – previously expected by 2025 – may be delayed a year. </p>
<p>The analysts remain confident that the company can deliver a 15%+ revenue CAGR through 2025, but believe pricing adjustments will now only partially offset raw material inflation, putting pressure on near-term margins.</p>

NASDAQ:OMCL